The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2

BACKGROUND/AIMS: Real-world, clinical practice data are lacking about sofosbuvir/ribavirin (SOF/RBV) treatment of Korean patients with hepatitis C virus genotype 2 (HCV GT2) infection. This study investigated the efficacy and safety of SOF/RBV in Korean patients with HCV GT2 infection and clinical f...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Korean J Intern Med
Egile Nagusiak: Han, Sung Yong, Woo, Hyun Young, Heo, Jeong, Park, Sang Gyu, Pyeon, Sung Ik, Park, Young Joo, Kim, Dong Uk, Kim, Gwang Ha, Kim, Hyung Hoi, Song, Geun Am, Cho, Mong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Association of Internal Medicine 2021
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8137398/
https://ncbi.nlm.nih.gov/pubmed/30879288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2018.329
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak